SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical, Inc., a leading developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical, Inc. announces that the first patients have been enrolled in its DEEPER OUS clinical trial using the Temporary Spur Stent System. DEEPER OUS is a ...

Reflow Medical, a cardiovascular disease-focused medical device company, today announced it has received a CE Mark for the Bare Temporary Spur Stent System to treat de novo or restenotic lesions in ...

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo ...

Reflow Medical, Inc. announced that it has received FDA commercial clearance for its coraCatheters™, a complete line of state-of-the-art microcatheters engineered to access and cross complex and ...

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of ...

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arecor, Biolabs, Danaher, Edwards, Elekta, Medtronic, Philips, Pulse Biosciences, Reflow ...

SCOTTSDALE, Ariz., March 20, 2025 /PRNewswire/ -- Anuncia Medical, Inc. ("Anuncia"), a pioneering company in CSF management and neurocritical care, has received Breakthrough Device Designation from ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aurora Spine, ICU Medical Lungpacer Medical, Reflow Medical, Skincure Oncology, Smiths Medical.